W 787 (Carbidopa, entacapone and levodopa 50 mg / 200 mg / 200 mg)
Pill imprint W 787 has been identified as Carbidopa, entacapone and levodopa 50 mg / 200 mg / 200 mg.
Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 50 mg / 200 mg / 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for W 787 (Carbidopa, entacapone and levodopa 50 mg / 200 mg / 200 mg)
More about carbidopa/entacapone/levodopa
- Carbidopa, entacapone, and levodopa
- Carbidopa, entacapone, and levodopa (Advanced Reading)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...